組織型纖溶酶原激活因子(tPA)單克隆抗體
Monoclonal Antibody to Tissue Plasminogen Activator (tPA)
PLAT; T-PA; t-plasminogen activator; Alteplase; Reteplase
- 編號MAA525Hu26
- 物種Homo sapiens (Human，人) 相同的名稱，不同的物種。
- 來源單抗制備
- 宿主小鼠
- 效價(克隆號)K12
- Ig亞型 IgG2b Kappa
- 純化方式蛋白A + 蛋白G親和純化
- 標記物無標記物
- 免疫原 EPA525Hu62-組織型纖溶酶原激活因子(tPA)真核蛋白
- 緩沖液成份0.01M 磷酸鹽緩沖液（pH7.4，containing 0.05% Proclin-300，50% glycerol）
- 性狀液體
- 濃度1mg/ml
- 且適物種Rattus norvegicus (Rat，大鼠), Sus scrofa; Porcine (Pig，豬)
- 應用WB; IHC; ICC; IP.
如果抗體需用于流式細胞術，請參見流式抗體。 - 下載 英文說明書 中文說明書
- 規格 20μl100μl 200μl 1ml 10ml
- 價格 ¥ 648 ¥ 1512 ¥ 2160 ¥ 5400 ¥ 21600
- 欲了解實際交易價格和更多情況，請與當地經銷商聯系!
-
產品包裝(模擬)
-
產品包裝(模擬)
-
Western Blot; Sample: Lane1: Human Serum; Lane2: Human Plasma; Lane3: Porcine Serum; Lane4: Rat Mammary gland lysate Primary Ab: 4μg/ml Mouse Anti-Human tPA Antibody Second Ab: 0.2μg/mL HRP-Linked Caprine Anti-Mouse IgG Polyclonal Antibody (Catalog: SAA544Mu19)
-
通過ISO 9001、ISO 13485質量體系認證
特異性
該抗體是針對tPA的小鼠單克隆抗體。在免疫組織化學染色和免疫印跡實驗中能識別tPA。
用法
Western blotting: 0.5-2μg/mL
Immunohistochemistry: 5-20μg/mL
Immunocytochemistry: 5-20μg/mL
Optimal working dilutions must be determined by end user.
儲存
經常使用則4°C保存。-20°C保存不超過兩年。避免反復凍融。
穩定性
熱穩定性以損失率顯示。損失率是由加速降解試驗決定，具體方法如下：在37°C孵育48小時，沒有顯著的降解或者沉淀產生。保質期內，在適當的條件下存儲，損失率低于5%。
贈品
增值服務
相關產品
| 編號 | 適用物種：Homo sapiens (Human，人) | 應用(僅供研究使用，不用于臨床診斷！) |
| RPA525Hu04 | 組織型纖溶酶原激活因子(tPA)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPA525Hu05 | 組織型纖溶酶原激活因子(tPA)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPA525Hu06 | 組織型纖溶酶原激活因子(tPA)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPA525Hu02 | 組織型纖溶酶原激活因子(tPA)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| EPA525Hu62 | 組織型纖溶酶原激活因子(tPA)真核蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPA525Hu01 | 組織型纖溶酶原激活因子(tPA)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPA525Hu03 | 組織型纖溶酶原激活因子(tPA)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| APA525Hu61 | 組織型纖溶酶原激活因子(tPA)活性蛋白 | Cell?culture;?Activity?Assays. |
| APA525Hu62 | 組織型纖溶酶原激活因子(tPA)活性蛋白 | Cell?culture;?Activity?Assays. |
| EPA525Hu61 | 組織型纖溶酶原激活因子(tPA)真核蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAA525Hu01 | 組織型纖溶酶原激活因子(tPA)多克隆抗體 | WB; IHC; ICC; IP. |
| PAA525Hu02 | 組織型纖溶酶原激活因子(tPA)多克隆抗體 | WB; IHC; ICC; IP. |
| FAA525Hu01 | 抗組織型纖溶酶原激活因子(tPA)多克隆抗體 | Flow cytometry. |
| MAA525Hu22 | 組織型纖溶酶原激活因子(tPA)單克隆抗體 | WB; IHC; ICC; IP. |
| MAA525Hu24 | 組織型纖溶酶原激活因子(tPA)單克隆抗體 | WB; IHC; ICC; IP. |
| MAA525Hu26 | 組織型纖溶酶原激活因子(tPA)單克隆抗體 | WB; IHC; ICC; IP. |
| MAA525Hu23 | 組織型纖溶酶原激活因子(tPA)單克隆抗體 | WB; IHC; ICC; IP. |
| MAA525Hu21 | 組織型纖溶酶原激活因子(tPA)單克隆抗體 | WB; IHC; ICC; IP. |
| MAA525Hu28 | 組織型纖溶酶原激活因子(tPA)單克隆抗體 | WB; IHC; ICC; IP. |
| MAA525Hu25 | 組織型纖溶酶原激活因子(tPA)單克隆抗體 | WB; IHC; ICC; IP. |
| MAA525Hu27 | 組織型纖溶酶原激活因子(tPA)單克隆抗體 | WB; IHC; ICC; IP. |
| MAA525Hu29 | 組織型纖溶酶原激活因子(tPA)單克隆抗體 | WB; IHC; ICC; IP. |
| FAA525Hu02 | 抗組織型纖溶酶原激活因子(tPA)單克隆抗體 | Flow cytometry. |
| FAA525Hu04 | 抗組織型纖溶酶原激活因子(tPA)單克隆抗體 | Flow cytometry. |
| FAA525Hu06 | 抗組織型纖溶酶原激活因子(tPA)單克隆抗體 | Flow cytometry. |
| SEA525Hu | 組織型纖溶酶原激活因子(tPA)檢測試劑盒(酶聯免疫吸附試驗法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| LMA525Hu | 組織型纖溶酶原激活因子(tPA)等多因子檢測試劑盒(流式熒光發光法) | FLIA Kit for Antigen Detection. |
參考文獻
| 雜志 | 參考文獻 |
| Annals of Clinical & Laboratory Science | Alteration of Hemostatic Parameters in Patients with Different Levels of Subclinical Hypothyroidism and the Effect of L-thyroxine Treatment [pubmed:28249913] |
| Cellular Physiology and Biochemistry | Defective Platelet Activation and Bleeding Complications upon Cholestasis in Mice [pubmed:28441661] |
| Journal of allergy and clinical immunology | Cytokine and estrogen stimulation of endothelial cells augments activation of the prekallikrein-high molecular weight kininogen complex: Implications for hereditary angioedema. [pubmed:27826093] |
| European Journal of Neuroscience | Urokinase receptor and tissue plasminogen activator as immediate‐early genes in pentylenetetrazole‐induced seizures in the mouse brain [Pubmed: 31587391] |
| Phytomedicine | Sodium aescinate significantly suppress postoperative peritoneal adhesion by inhibiting the RhoA/ROCK signaling pathway [Pubmed: 32120245] |
| Sci Rep | Fibroblast growth factor-21 as a novel metabolic factor for regulating thrombotic homeostasis [Pubmed:35013379] |
留言咨詢
